Just saw that Capital One posted IB applications for capital markets (leveraged finance, derivatives, structured products) and M&A (Kipps and Triple Tree).
Does anyone have any insight into their presence and maybe growth trajectory? Would starting off in capital markets there be a good opportunity to get one’s foot in the door? Thanks!
| +125 | UBS Americas IB: The Kids’ Table of Wall Street | 15 | 2d |
| +76 | Return Rates For Interns Are Falling? | 32 | 16m |
| +61 | London IB BB is a challenge | 38 | 2h |
| +52 | VP Lifestyle at Top BB Coverage Groups | 32 | 37m |
| +52 | I am a drunk MD AMA | 29 | 55m |
| +46 | SharePoint makes IB hours HELL | 15 | 1d |
| +46 | An Outsider’s View of RX Banking Out of College | 6 | 4h |
| +41 | momentum of Rx groups | 13 | 2h |
| +38 | Fired during interview | 7 | 4h |
| +27 | Series 79 Help | 13 | 13h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Anything is better than nothing man
Small IB group within CapitalOne itself, TripleTree and Kipps are much more established and do very well in their respective niches. TT in particular kills it in the MM Healthcare IT and Tech verticals and seems to be winning larger mandates recently. Comp is street (if not slightly higher) so great place to be if you value deal reps and don’t care about prestige.
Thanks for the reply. Do you think it’s a place that could allow for lateral opportunities to other banks down the line?
TT gives you a lot of lateral opportunities or even MM PE placement, but will be wary that there’s a massive waiting list for Analysts to change to NY office, so you will most likely be in Minneapolis for at least a year.
Bump, also interested
TT and Kipps are both established in their fields and they are focusing on growing the financing side. They have a pretty large balance sheet so they are able to get in on some pretty big syndications and structured deals. Have started to be lead on a few and seem to be on an upward trajectory.
COS has done a few lead left/joint book runner deals and from what I see they are lean and effective. TT’s presence in Healthcare & IT is reputable and their NYC headcount is growing. Kipps is an established ADG player on the sell-side with an upside in growth since more PE shops are buying.
Do you think the capital markets side has a longer term growth trajectory or best to look elsewhere?
anyone heard abt interviews?
No word but I heard via a VP that the process should be fast
Did the SA interview process with C1, whole process took less than a month.
What did it look like? How many rounds/was it very technical?
Kipps and TT do well in the middle market with regards to their mandate (A&D and healthcare).
anyone willing to chat about TT?
Voluptates quia autem nobis laborum. Voluptas quidem laboriosam rem non error qui amet. Perferendis necessitatibus dolore quasi vel impedit sit. Aut sunt molestiae aut assumenda. Dolorem eaque in voluptas et qui eaque vero optio. Libero suscipit ex ut aut sit explicabo.
Magni est consequatur eum aperiam. Laudantium autem animi voluptatem voluptatibus esse. Aliquam ut et dolorum omnis. Possimus rerum quia omnis nesciunt autem doloremque debitis.
Hic voluptatem est quia sit quos atque maiores cupiditate. Sunt est omnis praesentium. Ea id recusandae quae sint. Fugit ducimus consequatur non voluptatum maxime dolores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...